Cite
HARVARD Citation
Nozaki, Y. et al. (2020). Efficacy of iguratimod vs. salazosulfapyridine as the first-line csDMARD for rheumatoid arthritis. Modern rheumatology. 30 (2), pp. 249-258. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nozaki, Y. et al. (2020). Efficacy of iguratimod vs. salazosulfapyridine as the first-line csDMARD for rheumatoid arthritis. Modern rheumatology. 30 (2), pp. 249-258. [Online].